New funds, new partners: Seattle’s Presage Biosciences announced $13 million in funding as well new collaborations with biotech giant Merck and California-based Maverick Therapeutics. Presage is a biotech device company… Read More
Cancer technology maker Presage Biosciences has raised $6 million and appointed a new CEO as it moves to support the wider use of its cancer drug testing device. Biotech giants… Read More